|
Tuesday, March 20 — 8:00 AM — CC 211-214
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section C - Hematopathology
Chaired by: Robert Lorsbach and Pei Lin
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Novel Recurrent Gains and Deletions in Adults with Anaplastic Large Cell Lymphoma
(1422)
SD Held, MC Kinney, EA Medina, RA Higgins - University of Texas Health Science Center at San Antonio, San Antonio, TX
|  Add |
| 8:15 |
Rearrangements at the 6p25.3 Locus Identify a Subset of Systemic ALK-Negative Anaplastic Large Cell Lymphomas with Favorable Prognosis
(1508)
ER Parrilla Castellar, KL Grogg, ME Law, G Vasmatzis, SM Ansell, A Dogan, AL Feldman - Mayo Clinic, Rochester, MN
| Add |
| 8:30 |
NOTCH1 Intracellular Domain Immunohistochemistry as a Diagnostic Tool To Distinguish T-Lymphoblastic Lymphoma from Thymoma
(1442)
AG Jegalian, J Bodo, TR Holzer, JM Grondin, AD Fulford, BL Ackermann, RJ Konrad, A Nasir, AE Schade, ED Hsi - Cleveland Clinic, Cleveland, OH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
| Add |
| 8:45 |
Negative TdT Expression Predicts Adverse Treatment Outcome in T-Lymphoblastic Leukemia/Lymphoma in Adults
(1614)
Y Zhou, M Routbort, KH Young, S Wang, D Hoehn, G Tang, C Bueso-Ramos, CC Yin, RN Miranda, LJ Medeiros, P Lin - The University of Texas, MD Anderson Cancer Center, Houston, TX
| Add |
| 9:00 |
MicroRNA Profiles of the Bone Marrow Microenvironment and Serum in Multiple Myeloma Reveal Micrornas in the Serum Associated with Myeloma
(1369)
KR Calvo, W Wang, M Corrigan-Cummins, A Zingone, R Costello, N Korde, I Ghobrial, O Landgren - NIH Clinical Center, Bethesda, MD; National Cancer Institute, Bethesda, MD; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
| Add |
| 9:15 |
Plasma Cell Distribution within the Vascular Niche and Micro- Vessel Density Correlate with Gene Expression Profile
(1536)
ME Salama, F Zhan, H Lange, J Kohan, N Landis, S Tripp, J Kruger, S Potts - University of Utah, Salt Lake CIty; Flagship Biosciences, Flagstaff
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
Target Genes Associated with Micro RNA Profiles in Patients with Chronic Lymphocytic Leukemia
(1559)
S Srivastava, H Steinmetz, GJ Tsongalis, P Kaur - Dartmouth Medical School, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH
| Add |
| 11:15 |
Biological Subgroups of Chronic Lymphocytic Leukemia with Isolated 13q14 Deletion
(1529)
P Reddy, B Dabbas, D Keen-Kim, Y Xu - Genoptix Medical Lab, A Novartis Company, Carlsbad
| Add |
| 11:30 |
The Utility of LEF-1 Immunohistochemical Stain in the Diagnosis of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
(1587)
DW Warden, S Ondrejka, L Durkin, J Bodo, ED Hsi - Cleveland Clinic, Cleveland, OH
| Add |
| 11:45 |
Utility of the GPI-Linked Antigen CD157 in the Diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH) by Flow Cytometry: Advantages over CD14 for Analysis of Monocytes
(1374)
P Challagundla, JL Jorgensen - UT MD Anderson Cancer Center, Houston, TX
| Add |
|
|
